Wird geladen...
Development and dosimetry of (203)Pb/(212)Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
PURPOSE: The aims of this study were to develop a prostate-specific membrane antigen (PSMA) ligand for labelling with different radioisotopes of lead and to obtain an approximation of the dosimetry of a simulated (212)Pb-based alpha therapy using its (203)Pb imaging analogue. METHODS: Four novel Glu...
Gespeichert in:
| Veröffentlicht in: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6451745/ https://ncbi.nlm.nih.gov/pubmed/30603987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4220-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|